SDK BioTechnologies is developing enabling, high value added solutions for pre-clinical research and clinical diagnostics through the integration of innovative design, advanced materials and outstanding engineering. The main product is a new platform for multiplex binding assays that solves the reagents cross-reactivity issue. SDK’s technology will shorten the development time, improve the efficiency and lower the price per data point of present and future medical tests.